Pres, Innovation, Tech Aubrey Rankin sold $842K of Revance Therapeutics, Inc.

Sold$842,216

$25.43Price

33,119Shares

−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Mar 4. Filed Fri, Mar 5, 3:10 PM ET, during the session. Not investment advice.